Cel-Sci Corp (CVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,921 | -20,811 | -13,954 | -6,710 | -32,194 |
| Depreciation Amortization | 3,969 | 2,978 | 1,993 | 1,005 | 3,958 |
| Accounts payable and accrued liabilities | -461 | -592 | -897 | -765 | 258 |
| Other Working Capital | -1,212 | -652 | -926 | -837 | -1,777 |
| Other Operating Activity | 5,813 | 5,084 | 4,368 | 2,419 | 6,907 |
| Operating Cash Flow | $-18,811 | $-13,995 | $-9,416 | $-4,888 | $-22,849 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -95 | -75 | -52 | -52 | -362 |
| Purchase Sale Intangibles | -13 | -13 | -13 | -13 | -10 |
| Other Investing Activity | -13 | -13 | -13 | -13 | -10 |
| Investing Cash Flow | $-108 | $-88 | $-65 | $-65 | $-372 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 450 | N/A | N/A | N/A | N/A |
| Debt Repayment | -1,773 | -1,315 | -867 | -427 | -1,561 |
| Common Stock Issued | 23,575 | 12,730 | 12,730 | 4,980 | 7,000 |
| Other Financing Activity | -2,740 | -1,093 | -1,219 | -505 | -745 |
| Financing Cash Flow | $19,512 | $10,322 | $10,644 | $4,049 | $4,694 |
| Beginning Cash Position | 4,146 | 4,146 | 4,146 | 4,146 | 22,672 |
| End Cash Position | 4,738 | 385 | 5,309 | 3,241 | 4,146 |
| Net Cash Flow | $592 | $-3,761 | $1,164 | $-904 | $-18,526 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,811 | -13,995 | -9,416 | -4,888 | -22,849 |
| Capital Expenditure | -95 | -75 | -52 | -52 | -362 |
| Free Cash Flow | -18,906 | -14,070 | -9,467 | -4,940 | -23,211 |